Home › Research › Topics › mk6240
mk6240
6 studies tagged mk6240, dated 2020-09-24 to 2022-11-29. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer's disease, corticobasal degeneration and progressive supranuclear palsy brains 2022-11-29
- The Association of Age-Related and Off-Target Retention with Longitudinal Quantification of [18F]MK6240 Tau PET in Target Regions 2022-11-17
- Plasma p217+tau versus NAV4694 amyloid and MK6240 tau PET across the Alzheimer's continuum 2022-04-05
Studies
6 studies carry this tag.
Date range
2020 to 2022
Top journals
- European journal of nuclear medicine and molecular imaging 2
- Alzheimer's & dementia (Amsterdam, Netherlands) 1
- EBioMedicine 1
- Journal of nuclear medicine : official publication, Society of Nuclear Medicine 1
- Molecular psychiatry 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
Recent mechanistic and structural studies have challenged the classical tauopathy classification approach and revealed the complexity and heterogeneity of tau pathology in Alzheimer's disease (AD) and primary tauopathies such as corticobasal degeneration (CBD) and progressive supranuclear palsy (PSP), progressing beyond distinct tau isoforms.
-
Inferior cerebellar gray matter SUV did not differ on the basis of diagnosis and amyloid-β status, cross-sectionally and over time. [ 18 F]MK6240 uptake significantly differed between CUY and CU adults in the putamen or pallidum (affecting ∼75% of the region) and in the Braak II region (affecting ∼35%).
-
Plasma p217+tau levels elevate early in the AD continuum and correlate well with Aβ and tau PET.
-
The threshold for positivity was 15.085 pg/mL for plasma pTau181 and 17.652 pg/mL for plasma pTau231.
-
The temporal meta-ROI can be used for differential diagnosis of dementia patients with [ 18 F]flortaucipir, [ 18 F]RO948, and [ 18 F]MK6240 tau PET with high accuracy, and that using very similar cut-offs of around 1.35 SUVR.
-
43/100
3 H-MK6240 has a high binding affinity for tau deposits in AD brain tissue but also has different binding characteristics from those of the first-generation tau tracers.